ACN
56
2
BAC
77
5
AVGO
54
12
CNP
49
-6
BWA
53
-7
CMS
60
-2
BEN
55
2
AEE
51
-7
BA
47
4
AVB
34
-3
D
41
-4
APA
53
5
EFX
54
2
BAX
38
-12
CSCO
64
6
AZO
42
-3
ALLE
44
3
BF.B
48
-2
AKAM
64
2
BRK.B
33
-14
ACN
56
2
BAC
77
5
AVGO
54
12
CNP
49
-6
BWA
53
-7
CMS
60
-2
BEN
55
2
AEE
51
-7
BA
47
4
AVB
34
-3
D
41
-4
APA
53
5
EFX
54
2
BAX
38
-12
CSCO
64
6
AZO
42
-3
ALLE
44
3
BF.B
48
-2
AKAM
64
2
BRK.B
33
-14
Financhill
Back

Gabelli Financial Services Opportunities ETF Vs. Monopar Therapeutics, Inc. Sector Stock Comparison

Sell
28

GABF
Gabelli Financial Services Opportunities ETF

Last Price:
$47.04
Seasonality Move:
-0.61%
Sell
31

MNPR
Monopar Therapeutics, Inc.

Last Price:
$69.11
Seasonality Move:
25.93%
Sell
28
Gabelli Financial Services Opportunities ETF (GABF) is a Sell

Is Gabelli Financial Services Opportunities ETF a Buy, Sell or Hold?

  • The current Gabelli Financial Services Opportunities ETF [GABF] share price is $47.19. The Score for GABF is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
  • GABF is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
31
Monopar Therapeutics, Inc. (MNPR) is a Sell

Is Monopar Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Monopar Therapeutics, Inc. [MNPR] share price is $68.63. The Score for MNPR is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
  • MNPR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

GABF Stock Price Chart

What is Gabelli Financial Services Opportunities ETF's stock price today?

MNPR Stock Price Chart

What is Monopar Therapeutics, Inc.'s stock price today?

  • The Monopar Therapeutics, Inc. share price today is $68.63
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MNPR is experiencing slight buying pressure.

GABF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.27 Buy
Relative Strength Index (14 RSI): 56.39 Buy
Chaikin Money Flow: -1317 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (45.1 - 47.22) Buy
Bollinger Bands (100): (46.21 - 48.67) Sell

MNPR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.61 Sell
Relative Strength Index (14 RSI): 37.25 Sell
Chaikin Money Flow: 166161 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (72.18 - 85.74) Sell
Bollinger Bands (100): (45.57 - 89.21) Buy

GABF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 47.27 Sell
20-day SMA: 46.51 Buy
50-day SMA: 46.5 Buy
200-day SMA: 46.14 Buy
8-day EMA: 47.06 Buy
20-day EMA: 46.73 Buy
50-day EMA: 46.74 Buy
200-day EMA: 46.31 Buy

MNPR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 72.35 Sell
20-day SMA: 78.65 Sell
50-day SMA: 81.47 Sell
200-day SMA: 52.32 Buy
8-day EMA: 71.44 Sell
20-day EMA: 75.9 Sell
50-day EMA: 76.79 Sell
200-day EMA: 56.68 Buy

Gabelli Financial Services Opportunities ETF Earnings Growth & GABF Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Monopar Therapeutics, Inc. Earnings Growth & MNPR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.58 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and a decrease next year of $1.78 per share.

Gabelli Financial Services Opportunities ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Monopar Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):